Boothbay Fund Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-17,344
| Closed | -$81.3K | – | 1719 |
|
|
2024
Q3 | $81.3K | Buy |
+17,344
| New | +$81.3K | ﹤0.01% | 1279 |
|
|
2020
Q3 | – | Sell |
-298,605
| Closed | -$3.42M | – | 1121 |
|
|
2020
Q2 | $3.42M | Buy |
298,605
+20,505
| +7% | +$235K | 0.23% | 81 |
|
|
2020
Q1 | $2.88M | Buy |
278,100
+130,100
| +88% | +$1.35M | 0.24% | 87 |
|
|
2019
Q4 | $2.43M | Sell |
148,000
-1,139
| -0.8% | -$18.7K | 0.21% | 101 |
|
|
2019
Q3 | $1.98M | Buy |
149,139
+28,141
| +23% | +$374K | 0.18% | 119 |
|
|
2019
Q2 | $1.71M | Buy |
120,998
+85,064
| +237% | +$1.2M | 0.16% | 128 |
|
|
2019
Q1 | $661K | Buy |
35,934
+26,171
| +268% | +$481K | 0.06% | 240 |
|
|
2018
Q4 | $255K | Buy |
+9,763
| New | +$255K | 0.04% | 352 |
|
|
2018
Q2 | – | Sell |
-19,346
| Closed | -$326K | – | 796 |
|
|
2018
Q1 | $326K | Buy |
+19,346
| New | +$326K | 0.04% | 347 |
|